Established in 2002, our Thai operations offer an exemplary environment for clinical trials in an emerging market. The country's highly skilled workforce and large treatment population—which covers a broad range of disease profiles, including tropical diseases—makes Thailand an effective location for clinical trials. State-of-the-art medical services and infrastructure are also attractive features when choosing the country for trials.
Health Expenditure per Capita
Source: World Health Organization Global Health Expenditure Database
Life Expectancy at Birth
Source: The World Fact Book;
Central Intelligence Agency
Thailand: leading ASEAN in clinical research
In Thailand, clinical research is an emerging industry promoting healthcare innovation and economic prosperity. Of all the countries that make up the Association of Southeast Asian Nations (ASEAN), Thailand leads in clinical research ...
Thailand's struggle with multidrug-resistant falciparum malaria
In 1991, a clinical trial in Thailand was published proving that dosages of oral artesunate at 1200, 600 or 650 mg combined with 480 mg of intramuscular artemether to be an effective treatment for multidrug-resistant falciparum malaria ...
EPS Global Research (Thailand) Ltd.Suite 2967L Level 29, The Offices at Centralworld 999/9 Rama I Road, Pathumwan, Bangkok 10330 Thailand